coronavirus

Combatting COVID-19: 21 Innovative Efforts

Combatting COVID-19: 21 Innovative Efforts

We’re not sharing this information to scare, but instead to inform on the challenges the healthcare industry is facing. With that in mind, below we report on 21 innovative efforts from leading and emerging players in the biotech industry to combat the COVID-19 pandemic.

read more
EVQLV Submits First Panel of Optimized Antibody Sequences

EVQLV Submits First Panel of Optimized Antibody Sequences

EVQLV, has submitted their first panel of candidate therapeutic antibody sequences, comprised of DNA sequences encoding for potentially therapeutic antibodies against the new coronavirus, SARS-CoV-2. These DNA sequences were generated using computational antibody design, a method which combines mathematics, statistics, and computer science to identify high-affinity antibodies.

read more
Coronavirus Visualized

Coronavirus Visualized

Brett Averso, CTO, and I recently had a follow up discussion on our first coronavirus chat. Brett provided visualizations and commentary on coronavirus (SARS-CoV-2), ACE2, SARS-CoV-2 with SARS overlay, and antibody fragments to help people better understand the threat we’re currently facing, as well as put it in its proper context. Brett also discussed the role AI can play in finding an effective treatment for COVID-19.

read more
A Discussion on the Coronavirus (SARS-COV-2)

A Discussion on the Coronavirus (SARS-COV-2)

Brett Averso, CTO, and I linked up to discuss the coronavirus (SARS-CoV-2). Brett covered what exactly the coronavirus is, the threat it currently presents, how we can best protect ourselves and our loved ones against infection, and what EVQLV is doing to address the outbreak.

read more

Pin It on Pinterest